TY - JOUR
T1 - Aeromonas spp. and traveler's diarrhea
T2 - Clinical features and antimicrobial resistance
AU - Vila, Jordi
AU - Ruiz, Joaquin
AU - Gallardo, Francisco
AU - Vargas, Martha
AU - Soler, Lara
AU - Figueras, Maria José
AU - Gascon, Joaquin
PY - 2003/5/1
Y1 - 2003/5/1
N2 - Traveler's diarrhea is the most common health problem of international travelers. We determined the prevalence of Aeromonas spp. associated with traveler's diarrhea and analyzed the geographic distribution, clinical features, and antimicrobial susceptibility. Aeromonas spp. were isolated as a cause of traveler's diarrhea in 18 (2%) of 863 patients. A. veronii biotype sobria was isolated in nine patients, A. caviae in seven patients, and A. jandaei and A. hydrophila in one patient each. Aeromonas spp. were isolated with a similar prevalence in Africa, Latin America, and Asia. Watery and persistent diarrhea, fever, and abdominal cramps were common complaints. All strains were resistant to ampicillin; showed variable resistance to chloramphenicol, tetracycline, and cotrimoxazole; and were susceptible to cefotaxime, ciprofloxacin, and nalidixic acid. The persistence of symptoms made antimicrobial treatment necessary.
AB - Traveler's diarrhea is the most common health problem of international travelers. We determined the prevalence of Aeromonas spp. associated with traveler's diarrhea and analyzed the geographic distribution, clinical features, and antimicrobial susceptibility. Aeromonas spp. were isolated as a cause of traveler's diarrhea in 18 (2%) of 863 patients. A. veronii biotype sobria was isolated in nine patients, A. caviae in seven patients, and A. jandaei and A. hydrophila in one patient each. Aeromonas spp. were isolated with a similar prevalence in Africa, Latin America, and Asia. Watery and persistent diarrhea, fever, and abdominal cramps were common complaints. All strains were resistant to ampicillin; showed variable resistance to chloramphenicol, tetracycline, and cotrimoxazole; and were susceptible to cefotaxime, ciprofloxacin, and nalidixic acid. The persistence of symptoms made antimicrobial treatment necessary.
UR - http://www.scopus.com/inward/record.url?scp=0038415875&partnerID=8YFLogxK
U2 - 10.3201/eid0905.020451
DO - 10.3201/eid0905.020451
M3 - Artículo
C2 - 12737738
AN - SCOPUS:0038415875
SN - 1080-6040
VL - 9
SP - 552
EP - 555
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 5
ER -